Ryota Ando
Nagoya, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications
Multimodal Imaging in Indolent Nonprogressive Multifocal Choroidal Lesions: A Case Report.
Journal: Cureus
Published: April 19, 2026
Possible involvement of the mesenchymal cell marker Meflin in regeneration after retinal injury.
Journal: Scientific reports
Published: February 21, 2026
Multiple Evanescent White Dot Syndrome After mRNA COVID-19 Vaccination.
Journal: Cureus
Published: January 30, 2026
Increased Meflin Expression in Cancer-Associated Fibroblasts Restrains Tumor Cell Proliferation and Shapes Vessel-Rich Stroma in Triple-Negative Breast Cancer.
Journal: The American journal of pathology
Published: July 23, 2025
Local, but not circulating, complement C3 shapes immune checkpoint blockade efficacy by controlling myeloid cell infiltration.
Journal: Nature communications
Published: May 28, 2025
Meflin is a druggable target using antibody-drug conjugates in progressive osteosarcoma.
Journal: Oncogene
Published: March 31, 2025
Meflin/ISLR is a meningeal cell-specific marker involved in the development of meninges and meningioma progression.
Journal: Brain pathology (Zurich, Switzerland)
Published: March 26, 2025
Superoxide dismutase 2 deficiency in mesenchymal stromal cells induces sympathetic denervation and functional impairment of brown adipose tissue.
Journal: Pathology international
Published: November 02, 2024
Meflin/Islr is a marker of fibroblasts that arise in fibrotic regions after spinal cord injury.
Journal: Nagoya journal of medical science
Published: September 08, 2024
Meflin/ISLR is a marker of adipose stem and progenitor cells in mice and humans that suppresses white adipose tissue remodeling and fibrosis.
Journal: Genes to cells : devoted to molecular & cellular mechanisms
Published: May 07, 2024
Effects of Combination Therapy with Intravitreal Ranibizumab and Tissue Plasminogen Activator for Neovascular Age-Related Macular Degeneration.
Journal: Journal of clinical medicine
Published: February 07, 2024
Synthetic retinoid-mediated preconditioning of cancer-associated fibroblasts and macrophages improves cancer response to immune checkpoint blockade.
Journal: British journal of cancer
Published: November 29, 2023
Last Updated: 09/26/2026